Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Beckmann

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Journal of Molecular Biology|June 21, 2016
Dynamic Behavior of Trigger Factor on the RibosomeJ Deeng, K Y Chan, E O van der Sluis, et al.
Breast (Edinburgh, Scotland)|March 26, 2013
Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance ProjectEirene C Behm, Kerri R Beckmann, Jane E Dahlstrom, et al.
Breast (Edinburgh, Scotland)|May 11, 2010
Variation in the management of early breast cancer in rural and metropolitan centres: implications for the organisation of rural cancer servicesPaul S Craft, John M Buckingham, Jane E Dahlstrom, et al.
BMC Health Services Research|January 22, 2016
Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage studyKerri R Beckmann, Alice Bennett, Graeme P Young, et al.
Arzneimittel-Forschung|June 1, 1988
Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT2) alpha 1-receptor antagonistG Schröder, R Beckmann, K P Gerbling, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 22, 1999
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cellsJ Wojta, C Kaun, J M Breuss, et al.
BMC Cancer|August 12, 2017
Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupingsK R Beckmann, A D Vincent, M E O'Callaghan, et al.
The Prostate|March 7, 2022
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium databaseKerri R Beckmann, Chris H Bangma, Jozien Helleman, et al.
Perfusion|April 22, 2024
Effect of geography on the use of ultrafiltration during cardiac surgery with cardiopulmonary bypassKirti P Patel, Alfred H Stammers, Eric A Tesdahl, et al.
Clinical Genitourinary Cancer|June 4, 2017
Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and ValidityJared M Campbell, Michael E O'Callaghan, Elspeth Raymond, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Journal of Molecular Biology|June 21, 2016
Dynamic Behavior of Trigger Factor on the RibosomeJ Deeng, K Y Chan, E O van der Sluis, et al.
Breast (Edinburgh, Scotland)|March 26, 2013
Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the Breast Cancer Treatment Quality Assurance ProjectEirene C Behm, Kerri R Beckmann, Jane E Dahlstrom, et al.
Breast (Edinburgh, Scotland)|May 11, 2010
Variation in the management of early breast cancer in rural and metropolitan centres: implications for the organisation of rural cancer servicesPaul S Craft, John M Buckingham, Jane E Dahlstrom, et al.
BMC Health Services Research|January 22, 2016
Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage studyKerri R Beckmann, Alice Bennett, Graeme P Young, et al.
Arzneimittel-Forschung|June 1, 1988
Pharmacological profile of a new potent 5-hydroxytryptamine (5-HT2) alpha 1-receptor antagonistG Schröder, R Beckmann, K P Gerbling, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 22, 1999
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cellsJ Wojta, C Kaun, J M Breuss, et al.
BMC Cancer|August 12, 2017
Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupingsK R Beckmann, A D Vincent, M E O'Callaghan, et al.
The Prostate|March 7, 2022
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium databaseKerri R Beckmann, Chris H Bangma, Jozien Helleman, et al.
Perfusion|April 22, 2024
Effect of geography on the use of ultrafiltration during cardiac surgery with cardiopulmonary bypassKirti P Patel, Alfred H Stammers, Eric A Tesdahl, et al.
Clinical Genitourinary Cancer|June 4, 2017
Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and ValidityJared M Campbell, Michael E O'Callaghan, Elspeth Raymond, et al.
Pageof 22